|
|
||||||||
1From the Academic Department of Ophthalmology, The Rayne Institute, GKT Medical School, London, United Kingdom; the 2Vitreoretinal Unit, Moorfields Eye Hospital, London, United Kingdom; and the 3University Eye Clinic, University of Regensburg, Regensburg, Germany.
PURPOSE. To measure the specific hydraulic conductivity (K) of human sclera over a range of ages, to assess topographical variation, and to provide a theoretical estimate of potential scleral outflow facility.
METHODS. Human donor sclera (n = 18; mean age 56.7 ± 25.9 years; range 489) was clamped in a modified Ussing chamber connected to a water column set at 15.7 mm Hg. Column descent was measured over 24 hours at 20°C with a digital micrometer. Scleral thickness of glutaraldehyde-fixed specimens was measured by light microscopy, taking the mean of 15 measurements per donor. Topographical variation in hydraulic conductivity (HC) was determined in an additional 10 donor eyes (mean age, 54.1 ± 26.4 years; range 1289), comparing anterior, equatorial, and posterior sclera. The potential transscleral outflow facility was calculated by multiplying HC by total scleral surface area and adjusting water viscosity to core body temperature.
RESULTS. Mean K ± 1SD in adults (>18 years) was 5.85 ± 3.89 x 1018 m2. K tended to be higher in pediatric donors, but there was no statistically significant age-related change. However, when all data sets were combined (n = 28), HC showed a significant decline with age. There was no significant topographical variation in HC. The potential transscleral outflow facility was 0.33 µL · min1 · mm Hg1.
CONCLUSIONS. Quantifying HC may help refine ocular pharmacotherapy, as transscleral water movement increases intraocular drug elimination and impedes transscleral drug delivery. The potential scleral outflow is two to three times higher than that which occurs in vivo; hence, medical or surgical interventions that fully exploit this pathway have considerable capacity to lower intraocular pressure.
This article has been cited by other articles:
![]() |
J. M. Stewart, D. S. Schultz, O.-T. Lee, and M. L. Trinidad Exogenous Collagen Cross-linking Reduces Scleral Permeability: Modeling the Effects of Age-Related Cross-link Accumulation Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 352 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Jackson, A. Hussain, A. M. S. Morley, P. M. Sullivan, A. Hodgetts, A. El-Osta, J. Hillenkamp, S. J. Charles, R. Sheard, T. H. Williamson, et al. Scleral Hydraulic Conductivity and Macromolecular Diffusion in Patients with Uveal Effusion Syndrome Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5033 - 5040. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Anderson, T. L. Jackson, J. K. Singh, A. A. Hussain, and J. Marshall Human Transscleral Albumin Permeability and the Effect of Topographical Location and Donor Age Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4041 - 4045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ciancaglini, P. Carpineto, L. Agnifili, M. Nubile, V. Fasanella, and L. Mastropasqua Conjunctival Modifications in Ocular Hypertension and Primary Open Angle Glaucoma: An In Vivo Confocal Microscopy Study Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3042 - 3048. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |